| Pharmaceutical active ingredients: |
| Methylene Blue |
| Available forms, composition and doses of Collubleu: |
| N / A |
| Collubleu medical category: |
| Human:AntidotesMonoamine oxidase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AB17 - Methylthioninium Chloride |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Celltech |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Collu S | Carbocisteine; Lidocaine Hydrochloride; Neomycin Sulfate | Sanofi-Aventis |
| Collubiazol Pastilles | Benzocaine; Cetylpyridinium Chloride; Sulfachrysoidine Sodium | Millet-Franklin Laboratorios |
| Collubiazol Spray | Benzocaine; Sulfachrysoidine Sodium | Millet-Franklin Laboratorios |
| Collublache | Chlorhexidine Gluconate | Tradiphar Laboratoire |
| Collu-Blache | Chlorhexidine Gluconate; Oxybuprocaine Hydrochloride | Bausch and Lomb; Gallier Laboratoires |
| Collucalmyl | Hexamidine Isethionate; Tetracaine Hydrochloride | GlaxoSmithKline |
| Colludol | Hexamidine Isethionate; Lidocaine Hydrochloride | Sanofi-Aventis; Cooperation Pharmaceutique Francaise |
| Collu-Hextril | Hexetidine | Pfizer; Janssen; Ortho McNeil Pharmaceuticals |
| Collunosol | Chlorhexidine Gluconate; Lidocaine Hydrochloride | Sanofi-Aventis |
| Collunosol | 2,4,5-Trichlorophenol; Tetracaine Hydrochloride | Sodip |